Skip to Main Content

Paper Details

Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
PLoS One
3
2021
Patients, TIA, aspirin, atrial fibrillation, dabigatran, diabetes, diabetics, heart failure, patient, patients, stroke, systemic embolism, warfarin
Author NameAffiliation
Philip G JonesSaint Luke's Mid America Heart Institute
John A SpertusSaint Luke's Mid America Heart Institute
John A SpertusUniversity of Missouri-Kansas City
John A SpertusSaint Luke's Mid America Heart Institute
John A SpertusUniversity of Missouri-Kansas City
  • 1 - 5

Datasets

Release 1.2